Understanding Depression

Depression is one of the most common mental health conditions worldwide, yet it remains one of the most misunderstood. In everyday conversation, the word depression is often used to describe sadness, disappointment, loneliness, boredom, or a bad day. Clinical depression is different. It is not simply a failure to “stay positive,” a lack of gratitude, a weak personality, or an understandable excuse for avoiding responsibilities. It is a complex psychological and biological disorder that can affect mood, cognition, motivation, behaviour, physical functioning, relationships, work, and even a person’s sense of identity.

The World Health Organization (WHO) estimates that about 332 million people worldwide live with depression, with approximately 5.7% of adults affected. Depression can occur in people of any age, socioeconomic background, culture, educational level, or gender, although women are diagnosed more often than men (World Health Organization [WHO], 2025).

Understanding depression requires moving beyond simplistic explanations. The condition does not have one universal cause or one universal treatment. Genetic vulnerability, brain processes, personality, learning history, trauma, chronic stress, relationships, social disadvantage, physical illness, sleep, substance use, and environmental conditions may interact in different ways across individuals. Modern clinical psychology therefore increasingly views depression as heterogeneous rather than as a single disorder produced by a single biological abnormality (WHO, 2025; Cui et al., 2024).

This article examines depression from a biopsychosocial and clinical perspective, including its symptoms, diagnosis, causes, psychological mechanisms, risk factors, treatment, prevention, and common misconceptions.

1. What Is Depression?

Depression, clinically described in many cases as major depressive disorder (MDD), is characterized by a persistent disturbance in mood and/or loss of interest or pleasure accompanied by additional cognitive, behavioural, and physical symptoms that cause significant distress or impairment.

Everyone experiences sadness. People also experience grief, frustration, disappointment, loneliness, anger, and emotional exhaustion. These states can be intense without necessarily constituting a depressive disorder. Depression becomes clinically significant when symptoms persist, cluster together, and interfere with functioning.

The National Institute of Mental Health (NIMH) distinguishes ordinary temporary low mood from depression because depression can substantially affect how a person thinks, feels, sleeps, eats, works, and manages daily life (National Institute of Mental Health [NIMH], n.d.).

A depressive episode commonly involves symptoms occurring for most of the day, nearly every day, for at least two weeks, although clinical assessment should never be reduced to a simple checklist. The clinician must consider severity, functional impairment, medical causes, substance use, previous episodes, bipolar symptoms, psychotic symptoms, and the person’s broader psychosocial context (NIMH, n.d.; WHO, 2025).

One of the defining features of depression is that the individual may experience a reduction in the capacity to experience pleasure, known as anhedonia. A person may stop enjoying activities that previously felt meaningful, including hobbies, friendships, food, sexuality, religious activities, study, work, or even time with family. The problem is therefore not merely “feeling sad.” It can involve a profound alteration in motivation and reward experience.

2. Symptoms of Depression

Depression is multidimensional. Its symptoms can be understood across emotional, cognitive, behavioural, and physiological domains.

Emotional symptoms

The individual may experience persistent sadness, emptiness, hopelessness, irritability, guilt, shame, or emotional numbness. Not every person reports sadness. Some people primarily experience irritability or a feeling that they are emotionally “dead” or disconnected.

Cognitive symptoms

Depression can substantially alter thinking. Common cognitive symptoms include excessive guilt, low self-worth, pessimism, indecisiveness, reduced concentration, memory difficulties, and recurrent thoughts of death. A depressed person may increasingly interpret themselves, other people, and the future through a negative lens (NIMH, n.d.).

Typical depressive thinking may include:

• “I am a failure.”
• “Nothing I do matters.”
• “Things will never improve.”
• “Everyone would be better without me.”

These thoughts are clinically important because they can reinforce withdrawal, inactivity, hopelessness, and suicidal thinking.

Behavioural symptoms

Behavioural changes may include social withdrawal, reduced productivity, avoidance, loss of initiative, reduced self-care, increased substance use, and abandoning previously enjoyable activities. The person may stop responding to messages, cancel plans, remain in bed for long periods, or struggle to complete tasks that once seemed routine.

Physical symptoms

Depression frequently has a physical dimension. Sleep may become disrupted through insomnia, early-morning awakening, or excessive sleeping. Appetite may decrease or increase, resulting in changes in weight. Fatigue can become persistent, and some individuals experience headaches, gastrointestinal discomfort, generalized pain, or other unexplained physical complaints (NIMH, n.d.).

This is particularly important in cultures and healthcare systems where psychological distress is often expressed through bodily symptoms. A person may repeatedly report headaches, gastric problems, chest tightness, weakness, or sleep disturbance without initially recognizing an emotional component.

3. Depression Does Not Look the Same in Everyone

One of the greatest clinical mistakes is assuming that depression has a single appearance.

Children may present with irritability, school refusal, anxiety, somatic complaints, or behavioural changes rather than openly expressing sadness. Adolescents may show irritability, academic deterioration, social withdrawal, excessive sleeping, increased appetite, substance use, or conflict with parents. Adults may exhibit fatigue, loss of motivation, sleep disturbance, work impairment, and relationship difficulties. Older adults may report physical complaints, cognitive difficulties, emotional numbness, or loss of interest rather than explicitly saying that they feel depressed (NIMH, n.d.).

Men may be particularly likely to show depression through anger, irritability, substance use, risk-taking, overwork, withdrawal, or physical complaints rather than overt sadness. This does not mean that men experience a completely different disorder, but rather that depressive distress may be expressed and managed differently (NIMH, n.d.).

Depression also occurs in the context of pregnancy, postpartum adjustment, menopause, chronic illness, bereavement, and other major life transitions. Some individuals experience recurrent depressive episodes, while others experience a single episode. Depressive episodes can also occur in bipolar disorder, which makes assessment of past periods of elevated mood, decreased need for sleep, increased activity, impulsivity, racing thoughts, or unusually increased self-confidence essential (WHO, 2025; NIMH, n.d.).

4. Depression and Sadness Are Not the Same

Sadness is a normal human emotion. Depression is a clinical syndrome.

A person can be devastated after losing a job and still not have major depressive disorder. Likewise, someone can have depression despite having no obvious external reason for feeling distressed.

The distinction is not simply about severity. It also involves persistence, breadth of symptoms, functional impairment, cognitive changes, and whether the emotional response has developed into a broader depressive syndrome.

Grief deserves particular attention. Bereavement can involve profound sadness, crying, disrupted sleep, poor concentration, and temporary loss of interest. These reactions may overlap with depression without automatically constituting a depressive disorder. Clinical assessment therefore requires consideration of the person's history, symptoms, trajectory, functioning, and cultural context rather than applying crude rules such as “sadness after loss is normal, therefore it cannot be depression.”

The opposite mistake is equally problematic: assuming every period of sadness represents a mental disorder. Human beings were not designed to maintain constant happiness, despite what motivational posters have apparently decided.

5. Why Does Depression Happen?

There is no single cause of depression.

The most scientifically defensible explanation is that depression results from interacting biological, psychological, and social factors. These factors vary between people, and the same stressor can produce very different outcomes in different individuals (WHO, 2025).

Biological vulnerability

Genetics contribute to depression risk, although there is no single “depression gene.” Heritable vulnerability may influence temperament, stress sensitivity, emotional regulation, and other neurobiological processes.

Brain research has identified alterations involving networks associated with reward, emotion regulation, stress, cognition, and motivation. Neuroplasticity, inflammatory processes, endocrine regulation, neurotransmitter systems, and synaptic functioning are all being investigated as parts of the larger picture (Cui et al., 2024; Bertollo et al., 2024).

However, it is important to reject a simplistic biological narrative.

The popular statement that depression is simply caused by “low serotonin” is not an adequate scientific explanation. Contemporary research does not support reducing the disorder to a single neurotransmitter deficiency. Depression is heterogeneous, and biological mechanisms are considerably more complicated than the metaphor of a brain chemical being “too low” (Arnone et al., 2024; Page et al., 2024).

This distinction matters clinically. Antidepressants can help many people, but their effectiveness does not prove that depression is caused by a single chemical deficiency.

Psychological factors

Psychological processes can increase vulnerability to depression. These may include persistent negative thinking, self-criticism, perfectionism, low self-esteem, rumination, hopelessness, avoidance, emotional suppression, interpersonal difficulties, and maladaptive beliefs.

Beck’s cognitive model, for example, proposes that depression involves characteristic patterns of negative interpretation concerning the self, the world, and the future (Beck et al., 1979). In modern CBT, however, depression is not treated as simply “thinking negatively.” Behaviour, attention, memory, interpersonal processes, reinforcement patterns, and environmental contingencies also matter.

Social and environmental factors

Relationship breakdown, unemployment, financial stress, discrimination, social isolation, chronic conflict, caregiving burden, trauma, abuse, and major losses can increase the risk of depression. WHO emphasizes that adverse life events and stressful social circumstances are important contributors, while depression itself can then generate further dysfunction and stress, creating a vicious cycle (WHO, 2025).

This is one reason depression should not always be treated as a problem located entirely “inside the patient's head.” Sometimes the person is living in a genuinely painful environment.

6. The Psychological Cycle of Depression

One of the most useful ways to understand depression clinically is as a self-reinforcing cycle.

Imagine a person loses a job.

Initially, they experience sadness and anxiety. They begin thinking:

“I am useless.”

They lose confidence and stop contacting friends because they feel ashamed. As social contact decreases, they receive less emotional support and fewer opportunities for positive experiences. They stay at home more, become less physically active, and stop engaging in hobbies. Their routine deteriorates. Sleep worsens. They have more time to ruminate.

Now the person has even more evidence, from their own perspective, that life is empty and they are incapable.

The cycle may look like this:

Stress or loss → negative thoughts → withdrawal → reduced positive reinforcement → inactivity → worsening mood → more negative thoughts → further withdrawal.

Behavioural activation theory emphasizes this reduction in rewarding and meaningful environmental experiences as an important maintaining mechanism (Lewinsohn, 1974; Cuijpers et al., 2023). Evidence from recent meta-analysis supports behavioural activation as an effective psychological treatment for depression (Cuijpers et al., 2023).

CBT approaches the same vicious cycle by addressing interactions among thoughts, emotions, behaviour, physiology, and context.

7. Diagnosis and Clinical Assessment

Depression should be diagnosed through a clinical assessment, not solely through an online quiz or a score on a questionnaire.

Screening tools such as the Patient Health Questionnaire-9 (PHQ-9) can be highly useful for identifying depressive symptoms, estimating severity, and monitoring change over time. However, screening is not identical to diagnosis.

A proper assessment should examine:

• the onset and duration of symptoms;
• previous depressive episodes;
• severity and functional impairment;
• sleep and appetite;
• concentration and cognition;
• substance use;
• medical conditions;
• medications;
• trauma and significant life events;
• interpersonal and social factors;
• suicidal ideation and behaviour;
• psychotic symptoms when indicated;
• and possible bipolar-spectrum symptoms.

Medical conditions and medications can produce symptoms resembling depression. For example, thyroid disorders and some medical illnesses may contribute to depressive symptoms, which is why a responsible assessment includes consideration of physical health (NIMH, n.d.).

Clinicians must also distinguish depression from bipolar disorder. Treating a depressive episode without identifying a history of mania or hypomania can lead to inappropriate management.

The U.S. Preventive Services Task Force recommends screening adults for depression when systems are available to ensure appropriate diagnostic assessment and evidence-based care for those who screen positive (USPSTF, 2023).

8. Depression and Suicide Risk

Depression is strongly associated with suicidal thinking and behaviour, particularly when accompanied by severe hopelessness, agitation, substance misuse, psychotic symptoms, impulsivity, previous attempts, or major psychosocial stressors.

WHO reported more than 720,000 suicide deaths globally each year and emphasizes that suicide is influenced by biological, psychological, social, cultural, and environmental factors (WHO, 2025).

Therefore, asking about suicide should not be treated as an optional afterthought. When clinically indicated, assessment should directly explore thoughts of death, suicidal ideation, intent, plans, access to means, previous attempts, protective factors, and the person's immediate level of safety.

Importantly, asking a person about suicidal thoughts does not mean that the clinician is “putting the idea into their head.” Responsible clinical practice requires direct and compassionate assessment.

When there is imminent danger, emergency services or urgent psychiatric care may be necessary. The priority in such situations is safety, not philosophical debate about whether the person's suffering is “really that bad.”

9. Evidence-Based Psychological Treatment

Depression is treatable. Treatment should be individualized according to severity, preferences, comorbidity, previous response, availability, and clinical risk.

WHO recommends structured psychological interventions such as behavioural activation, cognitive behavioural therapy, interpersonal therapy, problem-solving therapy, and related evidence-based approaches for adults with moderate-to-severe depression (WHO, 2023).

Cognitive Behavioural Therapy

CBT remains one of the most extensively studied psychotherapies for depression.

CBT may target:

• automatic negative thoughts;
• cognitive distortions;
• core beliefs;
• avoidance;
• inactivity;
• rumination;
• behavioural patterns;
• and interpersonal or problem-solving difficulties.

Importantly, effective CBT is not simply “replace negative thoughts with positive thoughts.” It involves testing interpretations against evidence, developing more balanced perspectives, increasing adaptive behaviour, conducting behavioural experiments, solving practical problems, and building skills for future relapse prevention.

A large meta-analysis including 409 trials and more than 52,000 patients found substantial evidence supporting CBT for depression across different comparison conditions (Cuijpers et al., 2023).

Behavioural Activation

Behavioural activation focuses particularly on the behavioural patterns that maintain depression. The therapist helps the person identify avoidance, withdrawal, loss of routine, and reduced access to rewarding or meaningful experiences.

The central principle is deceptively simple:

Action does not always have to wait for motivation. Sometimes motivation follows action.

For a severely depressed person, this may begin with very small behavioural targets: getting out of bed, showering, walking outside, attending class, contacting one supportive person, or completing one manageable task.

Evidence indicates that behavioural activation is an effective treatment for depression, including in individual psychotherapy formats (Cuijpers et al., 2023).

Interpersonal Therapy

Interpersonal therapy (IPT) focuses on relationships and social roles. It may address grief, interpersonal disputes, role transitions, and interpersonal deficits. This approach is particularly valuable when depressive symptoms are closely linked with relationship changes, loss, loneliness, or communication difficulties.

Problem-Solving Therapy

Problem-solving therapy helps patients translate overwhelming problems into manageable steps. Instead of treating every difficulty as proof that life is hopeless, the patient learns to define problems precisely, generate possible solutions, evaluate them, implement a plan, and review the outcome.

This is particularly useful when practical stressors are contributing to depressive symptoms.

10. Medication and Combined Treatment

Antidepressant medication is another evidence-based treatment option.

Several classes of antidepressants are available, including selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). Large comparative analyses show that antidepressants differ in efficacy and acceptability, but multiple antidepressants are more effective than placebo on average in acute treatment of major depressive disorder (Cipriani et al., 2018).

Medication decisions should consider symptom severity, medical history, previous treatment response, adverse effects, patient preference, pregnancy or reproductive considerations where relevant, interactions with other medications, and risk factors.

NICE guidance emphasizes shared decision-making and does not recommend routinely offering antidepressants as first-line treatment for less severe depression unless this is the person's informed preference. For more severe depression, pharmacological treatment and psychological therapies may both be considered, depending on clinical needs and preferences (NICE, 2022, updated 2025).

WHO similarly recommends psychological treatment as an important treatment for depression and notes that antidepressants may be combined with psychological treatment in moderate-to-severe cases (WHO, 2025).

Medication should not be started, changed, or stopped without appropriate medical supervision. Some antidepressants produce discontinuation symptoms when abruptly stopped, and clinicians need to monitor treatment response and adverse effects.

11. Exercise, Sleep, and Lifestyle: Treatment or Mere Advice?

Lifestyle interventions are sometimes discussed dismissively as though telling a depressed person to “exercise and eat vegetables” were a substitute for psychotherapy or psychiatric treatment.

That is not the evidence-based position.

Exercise can meaningfully reduce depressive symptoms and can be used as part of a broader treatment plan. A large 2024 systematic review and network meta-analysis included 218 studies and more than 14,000 participants, finding beneficial effects for several forms of exercise, including walking or jogging, yoga, strength training, mixed aerobic exercise, and tai chi or qigong (Noetel et al., 2024).

The important clinical point is dosage and feasibility. A person with severe depression may not be able to begin with a demanding exercise program. A short walk may be more realistic than an ambitious gym routine.

Likewise, regular sleep and meal patterns, social connection, reduction of alcohol or illicit drug use, and gradual re-engagement with meaningful activities can support recovery (WHO, 2025).

These strategies should be treated as adjuncts or components of care, not as moral tests. Failure to exercise is not evidence of laziness; profound motivational impairment is itself a symptom of depression.

12. Depression in the Pakistani and South Asian Context

Culture influences how depression is experienced, interpreted, and communicated.

In many South Asian contexts, psychological symptoms may be described through physical complaints. A person may say:

• “My head feels heavy.”
• “My heart feels strange.”
• “I have no energy.”
• “My stomach is always upset.”
• “I cannot sleep.”
• “I do not enjoy anything anymore.”

Social expectations may further complicate treatment. Individuals may feel pressure to maintain family responsibilities, financial productivity, religious duties, academic performance, or social reputation regardless of mental health difficulties.

Stigma may cause people to interpret depression as weakness, lack of faith, lack of gratitude, poor character, or insufficient self-discipline. Spiritual beliefs can be a valuable source of meaning and support, but spiritual guidance should not be used to invalidate clinically significant suffering.

A culturally sensitive psychological approach therefore does not force Western terminology onto the patient. Instead, it explores how the person understands distress, what meanings they attach to symptoms, what social pressures exist, what sources of support are available, and how treatment can fit their cultural and religious framework.

13. Common Myths About Depression

Myth 1: “Depression means you are weak.”
Depression can occur in highly educated, successful, disciplined, ambitious, and resilient people. Determination does not provide immunity against mental illness.

Myth 2: “Just think positively.”
Positive thinking can become another demand placed upon someone who is already struggling. Effective therapy involves understanding patterns of thinking and behaviour, not forcing artificial optimism.

Myth 3: “Depression is just a chemical imbalance.”
This is an oversimplification. Biological mechanisms matter, but depression involves interacting psychological, biological, and social processes. The simplistic serotonin-deficiency explanation is not supported as a complete account of depression (Arnone et al., 2024; Page et al., 2024).

Myth 4: “People with depression should be grateful.”
Gratitude and depression can coexist. A person may recognize everything good in their life and still experience severe depressive symptoms.

Myth 5: “Talking about suicide makes people suicidal.”
Responsible suicide assessment is a core part of clinical care. Asking direct questions can help identify risk and facilitate intervention.

Myth 6: “Medication is the easy way out.”
Medication is not a moral shortcut. It is a legitimate medical intervention that may help appropriate patients. At the same time, medication is not necessary or sufficient for every person.

Myth 7: “Therapy is just talking.”
Evidence-based psychotherapy is structured clinical intervention involving assessment, formulation, therapeutic techniques, behavioural change, cognitive work, interpersonal processes, skills training, and relapse prevention.

14. Recovery and Relapse Prevention

Recovery from depression is not necessarily a simple return to the exact psychological state that existed before the illness.

Treatment aims not only to reduce symptoms but also to restore functioning, improve relationships, strengthen coping strategies, increase meaningful activity, address vulnerabilities, and reduce relapse risk.

Relapse prevention can involve recognizing early warning signs such as insomnia, withdrawal, rumination, loss of pleasure, reduced activity, hopelessness, and declining self-care. NICE recommends discussing continued treatment after remission when relapse risk is significant. Psychological strategies may include reviewing what was learned in therapy, identifying triggers, creating contingency plans, and maintaining protective routines (NICE, 2022).

This is important because residual symptoms matter. A person who is “better” but still severely isolated, inactive, hopeless, or ruminative may remain vulnerable to another episode.

The goal is therefore not merely:

“I am no longer severely depressed.”

A stronger goal is:

“I understand my vulnerabilities, recognize my warning signs, and know what to do when they appear.”

Conclusion

Depression is neither ordinary sadness nor a simple chemical defect. It is a complex and potentially disabling mental health disorder involving interconnected emotional, cognitive, behavioural, biological, interpersonal, and social processes.

Its clinical presentation can vary dramatically. Some people experience obvious sadness and crying. Others become irritable, emotionally numb, exhausted, physically unwell, socially withdrawn, or unable to experience pleasure. In severe cases, depression may involve profound hopelessness, psychotic symptoms, or suicidal thinking.

The encouraging fact is that depression is treatable. Evidence supports psychological therapies including CBT, behavioural activation, interpersonal therapy, and problem-solving approaches. Medication can also be effective, particularly when appropriately selected and monitored, and combined treatment may be appropriate for some people. Exercise, healthy routines, social connection, and attention to physical health can strengthen recovery but should not be presented as simplistic substitutes for clinical care (WHO, 2025; NICE, 2025).

Perhaps the most important conceptual shift is to stop asking, “Why can't this person simply get over it?” and instead ask, “What processes are maintaining this person's suffering, what vulnerabilities are present, and what evidence-based interventions can help?”

That shift moves depression from a moral judgment to a clinical problem.

And clinical problems, unlike moral failures, can be assessed, understood, treated, and managed.

References

Arnone, D., Wise, T., Fitzgerald, P. B., & Harmer, C. J. (2024). The involvement of serotonin in major depression: Nescience in disguise? Molecular Psychiatry, 29, 200–202. https://doi.org/10.1038/s41380-024-02459-y

Beck, A. T., Rush, A. J., Shaw, B. F., & Emery, G. (1979). Cognitive therapy of depression. Guilford Press.

Bertollo, A. G., Mingoti, M. E. D., & Ignácio, Z. M. (2024). Neurobiological mechanisms in the kynurenine pathway and major depressive disorder. Reviews in the Neurosciences, 36(2), 169–187. https://doi.org/10.1515/revneuro-2024-0065

Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., Egger, M., Takeshima, N., Hayasaka, Y., Imai, H., Shinohara, K., Tajika, A., Ioannidis, J. P. A., & Geddes, J. R. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. The Lancet, 391(10128), 1357–1366. https://doi.org/10.1016/S0140-6736(17)32802-7

Cui, L., Li, S., Wang, S., Wu, X., Yu, Y., Tang, Y., Xia, M., et al. (2024). Major depressive disorder: Hypothesis, mechanism, prevention and treatment. Signal Transduction and Targeted Therapy. https://doi.org/10.1038/s41392-024-01738-y

Cuijpers, P., Miguel, C., Harrer, M., Plessen, C. Y., Ciharova, M., Ebert, D., & Karyotaki, E. (2023). Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: A comprehensive meta-analysis including 409 trials with 52,702 patients. World Psychiatry, 22(1), 105–115. https://doi.org/10.1002/wps.21069

Cuijpers, P., Karyotaki, E., Harrer, M., & Stikkelbroek, Y. (2023). Individual behavioral activation in the treatment of depression: A meta-analysis. Psychotherapy Research, 33(7), 886–897. https://doi.org/10.1080/10503307.2023.2197630

Lewinsohn, P. M. (1974). A behavioral approach to depression. In R. M. Friedman & M. M. Katz (Eds.), The psychology of depression: Contemporary theory and research. Wiley.

National Institute of Mental Health. (n.d.). Depression. U.S. Department of Health and Human Services, National Institutes of Health.

National Institute for Health and Care Excellence. (2022, updated 2025). Depression in adults: Treatment and management (NG222). NICE.

Noetel, M., Sanders, T., Gallardo-Gómez, D., Taylor, P., Del Pozo Cruz, B., van den Hoek, D., Smith, J. J., Mahoney, J., Spathis, J., Moresi, M., Pagano, R., Pagano, L., Vasconcellos, R., Arnott, H., Varley, B., Parker, P., Biddle, S., & Lonsdale, C. (2024). Effect of exercise for depression: Systematic review and network meta-analysis of randomised controlled trials. BMJ, 384, e075847. https://doi.org/10.1136/bmj-2023-075847

Page, C. E., Epperson, C. N., et al. (2024). Beyond the serotonin deficit hypothesis: Communicating a neuroplasticity framework of major depressive disorder. Molecular Psychiatry.

U.S. Preventive Services Task Force. (2023). Screening for depression and suicide risk in adults: Recommendation statement. JAMA, 329(23), 2068–2085. https://doi.org/10.1001/jama.2023.7787

World Health Organization. (2023). Brief, structured psychological treatment for depression: mhGAP evidence centre. WHO.

World Health Organization. (2025, August 29). Depressive disorder (depression). WHO.

World Health Organization. (2025, March 25). Suicide. WHO.